Homologous and heterologous boosting with CoronaVac and BNT162b2: a randomized trial (the Cobovax study)

Nancy H. L. Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Mario Martín-Sánchez, Niki Y. M. Au, Leo L. H. Luk, Leo C. H. Tsang, Kelvin K. H. Kwan, Sara Chaothai, Lison W. C. Fung, Alan W. L. Cheung, Karl C. K. Chan, John K. C. Li, Yvonne Y. Ng, Prathanporn Kaewpreedee, Janice Z. Jia, Dennis K. M. Ip, Leo L. M. Poon, Gabriel M. Leung, J. S. Malik Peiris, Sophie A. Valkenburg, Benjamin J. Cowling
doi: https://doi.org/10.1101/2022.08.25.22279158

Article Information

doi 
https://doi.org/10.1101/2022.08.25.22279158
History 
  • August 26, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Nancy H. L. Leung*,1,2,#,
  2. Samuel M. S. Cheng*,1,
  3. Carolyn A. Cohen*,3,
  4. Mario Martín-Sánchez1,
  5. Niki Y. M. Au1,
  6. Leo L. H. Luk1,
  7. Leo C. H. Tsang1,
  8. Kelvin K. H. Kwan1,
  9. Sara Chaothai1,
  10. Lison W. C. Fung1,
  11. Alan W. L. Cheung3,
  12. Karl C. K. Chan1,
  13. John K. C. Li1,
  14. Yvonne Y. Ng1,
  15. Prathanporn Kaewpreedee3,
  16. Janice Z. Jia3,
  17. Dennis K. M. Ip1,
  18. Leo L. M. Poon1,3,4,
  19. Gabriel M. Leung†,1,2,
  20. J. S. Malik Peiris†,1,3,4,
  21. Sophie A. Valkenburg†,3,5 and
  22. Benjamin J. Cowling†,1,2,#
  1. 1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China
  2. 2Laboratory of Data Discovery for Health; Hong Kong Science and Technology Park, New Territories, Hong Kong Special Administrative Region, China
  3. 3HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China
  4. 4Centre for Immunology and Infection; Hong Kong Science and Technology Park, New Territories, Hong Kong Special Administrative Region, China
  5. 5Department of Microbiology and Immunology, Peter Doherty Institute of Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia
  1. ↵#Corresponding authors:
    Benjamin Cowling, WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong; Hong Kong Special Administrative Region, China. bcowling{at}hku.hk, Nancy Leung, WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong; Hong Kong Special Administrative Region, China. leungnan{at}hku.hk

  1. ↵* Joint first authors with equal contribution

  2. ↵† Joint senior authors with equal contribution

Back to top
Posted August 26, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Homologous and heterologous boosting with CoronaVac and BNT162b2: a randomized trial (the Cobovax study)
Nancy H. L. Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Mario Martín-Sánchez, Niki Y. M. Au, Leo L. H. Luk, Leo C. H. Tsang, Kelvin K. H. Kwan, Sara Chaothai, Lison W. C. Fung, Alan W. L. Cheung, Karl C. K. Chan, John K. C. Li, Yvonne Y. Ng, Prathanporn Kaewpreedee, Janice Z. Jia, Dennis K. M. Ip, Leo L. M. Poon, Gabriel M. Leung, J. S. Malik Peiris, Sophie A. Valkenburg, Benjamin J. Cowling
medRxiv 2022.08.25.22279158; doi: https://doi.org/10.1101/2022.08.25.22279158
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area